COHESION INFORMATION TECHNOLOGY Co., Ltd. (CohesionData for short), which core competitiveness lies in its medical information development, medical data understanding and AI development and application capabilities, helping medical experts gain excellent artificial intelligence application experience and expand preventive medicine auxiliary applications.
Milestones:
- Established a national cloud electronic medical record system in 2010.
- Assisted the country in testing the feasibility of personal health passbook in 2014.
- Develop digital health platform (workplace care, health management, personal health) in 2015.
- Launched the platform in 2017, with 50,000 online users.
- In 2018, a national health insurance massive data storage and AI platform was built.
- In 2019, (1)Develop and deploy high-speed image OCR anonymous, unsupervised learning human body part image recognition for national health insurance, (2)Complete HIPAA verification.
- In 2020, we will build an AI application management platform, chronic disease risk assessment, and image diagnosis quality-assisted detection AI.
- In 2021, we will assist the National Health Administration in building a national LDCT lung cancer AI screening platform.
- Pass ISO 27001:2013 certification in 2022.
- Passed the medical material manufacturing license (QMS2158) from the Ministry of Health and Welfare in 2023.
In 2024, LibraLung was approved as a medical device by the TFDA (Ministry of Health Medical Device No. 008042).
